The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Matsuyama, W., Watanabe, M., Shirahama, Y., Oonakahara, K.-I., Higashimoto, I., Yoshimura, T., Osame, M., & Arimura, K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6490 · Cited by 46
RetractedSuppression of Discoidin Domain Receptor 1 by RNA Interference Attenuates Lung Inflammation
Matsuyama, W., Watanabe, M., Shirahama, Y., Hirano, R., Mitsuyama, H., Higashimoto, I., Osame, M., & Arimura, K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1928 · Cited by 39
RetractedInvolvement of Discoidin Domain Receptor 1 in the Deterioration of Pulmonary Sarcoidosis
Matsuyama, W., Mitsuyama, H., Watanabe, M., Shirahama, Y., Higashimoto, I., Osame, M., & Arimura, K. (2005) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2005-0236oc · Cited by 21
RetractedComparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Overriding Imatinib Resistance with a Novel ABL Kinase Inhibitor
Shah, N. P., Tran, C., Lee, F. Y., Chen, P., Norris, D., & Sawyers, C. L. (2004) · Science · doi:10.1126/science.1099480 · Cited by 1,796
Shah, N. P., Nicoll, J. M., Nagar, B., Gorre, M. E., Paquette, R. L., Kuriyan, J., & Sawyers, C. L. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00096-x · Cited by 1,612
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
Weisberg, E., Manley, P. W., Breitenstein, W., Brüggen, J., Cowan-Jacob, S. W., Ray, A., Huntly, B., Fabbro, D., Fendrich, G., Hall-Meyers, E., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.007 · Cited by 1,492
Self-citationSCRATCH: a protein structure and structural feature prediction server
Cheng, J., Randall, A. Z., Sweredoski, M. J., & Baldi, P. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki396 · Cited by 1,044
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
The Discoidin Domain Receptor Tyrosine Kinases Are Activated by Collagen
Vogel, W., Gish, G. D., Alves, F., & Pawson, T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80003-9 · Cited by 1,002 · cited 1×
“1 nM for imatinib (panel D), nilotinib (panel E) and dasatin compared to most tyrosine kinases (Vogel et al., 1997) we next determined the optimum time required for collagen-induced DDR1 auto-phosphorylation.”
BackgroundNagar, B., Bornmann, W. G., Pellicena, P., Schindler, T. H., Veach, D. R., Miller, W. T., Clarkson, B. D., & Kuriyan, J. (2002) · PubMed · Cited by 923
Rix, U., Hantschel, O., Dürnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., et al. (2007) · Blood · doi:10.1182/blood-2007-07-102061 · Cited by 671
Weisberg, E., Manley, P. W., Cowan-Jacob, S. W., Hochhaus, A., & Griffin, J. D. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2126 · Cited by 636
Self-citationDaniels, C. E., Wilkes, M. C., Edens, M., Kottom, T. J., Murphy, S. J., LIMPER, A. H., & Leof, E. B. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19603 · Cited by 574
Sensing extracellular matrix: An update on discoidin domain receptor function
Vogel, W. F., Abdulhussein, R., & Ford, C. E. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2006.02.012 · Cited by 368
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia
Cowan-Jacob, S. W., Fendrich, G., Floersheimer, A., Furet, P., Liebetanz, J., Rummel, G., Rheinberger, P., Centeleghe, M., Fabbro, D., & Manley, P. W. (2007) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906047287 · Cited by 296
Self-citationDDR2 receptor promotes MMP-2–mediated proliferation and invasion by hepatic stellate cells
Olaso, E., Ikeda, K., Eng, F. J., Xu, L.-M., Wang, L., Lin, H. C., & Friedman, S. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12373 · Cited by 291
Imatinib as a Novel Antifibrotic Agent in Bleomycin-induced Pulmonary Fibrosis in Mice
Aono, Y., Nishioka, Y., Inayama, M., Ugai, M., Kishi, J., Uehara, H., Izumi, K., & Sone, S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-531oc · Cited by 231
Chemokine/Cytokine Cocktail in Idiopathic Pulmonary Fibrosis
Agostini, C., & Gurrieri, C. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200601-010tk · Cited by 197
Role of Discoidin Domain Receptors 1 and 2 in Human Smooth Muscle Cell-Mediated Collagen Remodeling
Ferri, N., Carragher, N. O., & Raines, E. W. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63716-9 · Cited by 173
Cowan-Jacob, S., Guez, V., Fendrich, G., Griffin, J., Fabbro, D., Furet, P., Liebetanz, J., Mestan, J., & Manley, P. (2004) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557043487321 · Cited by 163
Self-citationManley, P. W., Cowan-Jacob, S. W., & Mestan, J. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2005.07.040 · Cited by 160
Self-citationDiscoidin Domain Receptor 1–deficient Mice are Resistant to Bleomycin-induced Lung Fibrosis
Avivi-Green, C., Singal, M., & Vogel, W. F. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200603-333oc · Cited by 155
Discoidin Domain Receptor 1 Null Mice Are Protected against Hypertension-Induced Renal Disease
Flamant, M., Placier, S., Rodenas, A., Curat, C. A., Vogel, W. F., Chatziantoniou, C., & Dussaule, J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060677 · Cited by 135
Crystal Structure of the T315I Abl Mutant in Complex with the Aurora Kinases Inhibitor PHA-739358
Modugno, M., Casale, E., Soncini, C., Rosettani, P., Colombo, R., Lupi, R., Rusconi, L., Fancelli, D., Carpinelli, P., Cameron, A. D., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1825 · Cited by 132
Overexpression of Protein Tyrosine Kinases in Human Esophageal Cancer
Nemoto, T., Ohashi, K., Akashi, T., Johnson, J. D., & Hirokawa, K. (2008) · Pathobiology · doi:10.1159/000164123 · Cited by 130
Xu, L., Peng, H., Glasson, S. S., Lee, P. L., Hu, K., Ijiri, K., Olsen, B. R., Goldring, M. B., & Li, Y. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22761 · Cited by 122
Matsuyama, W., Wang, L., Farrar, W. L., Faure, M., & Yoshimura, T. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.4.2332 · Cited by 102
Crystal Structure of the T315I Mutant of Abl Kinase
Zhou, T., Parillon, L., Li, F., Wang, Y., Keats, J. A., Lamore, S. D., Xu, Q., Shakespeare, W. C., Dalgarno, D. C., & Zhu, X. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00556.x · Cited by 102
Shimada, K., Nakamura, M., Ishida, E., Higuchi, T., Yamamoto, H., Tsujikawa, K., & Konishi, N. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00655.x · Cited by 101
Expression patterns of the novel receptor-like tyrosine kinase, DDR, in human breast tumours.
Barker, K. T., Martindale, J. E., Pj, M., Kamalati, T., Mj, P., Phippard, D. J., Dale, T. C., Ba, G., & Crompton, M. R. (1995) · PubMed · Cited by 97
Weiner, H. L., Huang, H., Zagzag, D., Boyce, H., Lichtenbaum, R., & Ziff, E. B. (2000) · Neurosurgery · doi:10.1093/neurosurgery/47.6.1400 · Cited by 78
Park, H., Kim, K. M., Lee, H. C., Choi, H. N., Kim, D. J., Kim, B., & Moon, W. (2007) · Oncology Reports · doi:10.3892/or.18.6.1435 · Cited by 74
Yoshida, D., & Teramoto, A. (2006) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9246-6 · Cited by 51
Cited by
Extracellular matrix and its therapeutic potential for cancer treatment
Huang, J., Zhang, L., Wan, D., Zhou, L., Zheng, S., Lin, S., & Qiao, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00544-0 · Cited by 962
Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer
Hammerman, P. S., Sos, M. L., Ramos, A. H., Xu, C., Dutt, A., Zhou, W., Brace, L. E., Woods, B. A., Lin, W., Zhang, J., et al. (2011) · Cancer Discovery · doi:10.1158/2159-8274.cd-11-0005 · Cited by 482
Discoidin Domain Receptor Functions in Physiological and Pathological Conditions
(2014) · International Review of Cell and Molecular Biology · doi:10.1016/b978-0-12-800180-6.00002-5 · Cited by 395
Genetic alterations defining NSCLC subtypes and their therapeutic implications
Pikor, L. A., Ramnarine, V. R., Lam, S., & Lam, W. L. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.07.025 · Cited by 375
Imatinib in Pulmonary Arterial Hypertension Patients with Inadequate Response to Established Therapy
Ghofrani, H. A., Morrell, N. W., Hoeper, M. M., Olschewski, H., Peacock, A. J., Barst, R. J., Shapiro, S., Golpon, H., Toshner, M., Grimminger, F., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201001-0123oc · Cited by 384
Metadata
- Authors
- Day, E., Waters, B., Spiegel, K., Alnadaf, T., Manley, P. W., Buchdunger, E., Walker, C., & Jarai, G.
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 599
- Issue
- 1-3
- Pages
- 44-53
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2011852093
- Cited by
- 277
- References
- 34
- FWCI
- 5.71
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.